Los Angeles Times – Two major federal agencies are stocking up on hydroxychloroquine, a longtime anti-malarial medication touted by President Trump as a potential “game changer” in the coronavirus pandemic, amid experts’ warnings that its use for COVID-19 is risky and unproven.

Read More >

Contact Us

We're not around right now. But you can send us an email and we'll get back to you, asap.

Not readable? Change text. captcha txt

Start typing and press Enter to search